Literature DB >> 1417735

Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity.

H Chen1, E Born, S N Mathur, F C Johlin, F J Field.   

Abstract

Micellar cholesterol uptake and secretion were investigated in the human intestinal cell line CaCo-2 following depletion of apical membrane sphingomyelin. The addition of exogenous sphingomyelinase, which hydrolysed 60% of prelabelled sphingomyelin, resulted in a 50% decrease in the uptake of cholesterol from bile salt micelles. The flux of membrane cholesterol into the cell by the hydrolysis of membrane sphingomyelin decreased the rate of cholesterol synthesis by 43% and inhibited hydroxymethylglutaryl-CoA reductase activity by 54%. Moreover, the rate of cholesterol esterification was increased 4-fold. Total cellular cholesterol mass was unchanged by the addition of sphingomyelinase; however, cholesteryl esters increased by 50% and the amount of unesterified cholesterol decreased significantly. The basolateral secretion of cholesterol mass was also decreased following sphingomyelin hydrolysis. Human pancreatic juice was found to contain neutral sphingomyelinase activity which required taurocholate for full expression. The presence of neutral sphingomyelinase activity was also documented in membranes prepared from CaCo-2 cells and in whole homogenates from human duodenal biopsies. The data suggest that the amount of sphingomyelin present in the apical membrane of the intestinal absorptive cell regulates cholesterol uptake from bile salt micelles. Sphingomyelinase activity within intestinal cells and in pancreatic juice could alter the sphingomyelin content of brush-border membranes of small intestinal absorptive cells and thus regulate the amount of cholesterol absorbed by the gut.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417735      PMCID: PMC1132970          DOI: 10.1042/bj2860771

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

Review 1.  Intestinal aspects of lipid absorption: in review.

Authors:  A B Thomson; M Keelan; M L Garg; M T Clandinin
Journal:  Can J Physiol Pharmacol       Date:  1989-03       Impact factor: 2.273

2.  The uptake of phosphatidylcholine by small intestinal brush border membrane is protein-mediated.

Authors:  H Thurnhofer; H Hauser
Journal:  Biochim Biophys Acta       Date:  1990-05-24

3.  Regulation of cholesterol esterification by micellar cholesterol in CaCo-2 cells.

Authors:  F J Field; E Albright; S N Mathur
Journal:  J Lipid Res       Date:  1987-09       Impact factor: 5.922

4.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-03-04

5.  Intestinal cholesterol esterase: intracellular enzyme or contamination of cytosol by pancreatic enzymes?

Authors:  F J Field
Journal:  J Lipid Res       Date:  1984-04       Impact factor: 5.922

6.  Sterol partitioning among intracellular membranes. Testing a model for cellular sterol distribution.

Authors:  B W Wattenberg; D F Silbert
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

7.  Inhibition of acylcoenzyme A: cholesterol acyltransferase activity by PD128O42: effect on cholesterol metabolism and secretion in CaCo-2 cells.

Authors:  F J Field; E Albright; S Mathur
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

8.  Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies.

Authors:  S Chatterjee; N Ghosh
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

9.  Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts.

Authors:  S Gatt; E L Bierman
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

10.  Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts.

Authors:  J P Slotte; E L Bierman
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more
  11 in total

1.  Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions.

Authors:  Sivakumar Vijayaraghavalu; Chiranjeevi Peetla; Shan Lu; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2012-08-07       Impact factor: 4.939

2.  Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.

Authors:  Dan Feng; Lena Ohlsson; Wenhua Ling; Ake Nilsson; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

3.  Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung.

Authors:  R K Mallampalli; S N Mathur; L J Warnock; R G Salome; G W Hunninghake; F J Field
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

4.  Sphingolipids and Cholesterol.

Authors:  Xian-Cheng Jiang; Zhiqiang Li
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

6.  Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells.

Authors:  F J Field; H Chen; E Born; B Dixon; S Mathur
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences.

Authors:  R D Duan; E Hertervig; L Nyberg; T Hauge; B Sternby; J Lillienau; A Farooqi; A Nilsson
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

8.  Effect of dietary sphingomyelin on absorption and fractional synthetic rate of cholesterol and serum lipid profile in humans.

Authors:  Vanu R Ramprasath; Peter Jh Jones; Donna D Buckley; Laura A Woollett; James E Heubi
Journal:  Lipids Health Dis       Date:  2013-08-19       Impact factor: 3.876

9.  Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status.

Authors:  Elin Rebecka Carlsson; Josefine Liv Gilling Grundtvig; Sten Madsbad; Mogens Fenger
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-25       Impact factor: 5.555

10.  Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.

Authors:  Ying Chen; Shu-Chang Xu; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2015-10-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.